{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:31:58Z","timestamp":1791243118127,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018624","name":"Science and Technology Bureau of Quanzhou","doi-asserted-by":"publisher","award":["2024CT002"],"award-info":[{"award-number":["2024CT002"]}],"id":[{"id":"10.13039\/501100018624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3407000-2024YFC3407004"],"award-info":[{"award-number":["2024YFC3407000-2024YFC3407004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270918"],"award-info":[{"award-number":["82270918"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372362"],"award-info":[{"award-number":["82372362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370052"],"award-info":[{"award-number":["32370052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022J06003"],"award-info":[{"award-number":["2022J06003"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Translation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jot.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:46:05Z","timestamp":1759304765000},"page":"280-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites"],"prefix":"10.1016","volume":"55","author":[{"given":"Ning","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-0778","authenticated-orcid":false,"given":"Junliang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengye","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-0132","authenticated-orcid":false,"given":"Hao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6578-4553","authenticated-orcid":false,"given":"Ren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jot.2025.09.002_bib1","first-page":"52","article-title":"Diabetes and frailty","volume":"22","author":"Assar","year":"2019","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jot.2025.09.002_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.metabol.2018.10.011","article-title":"Obesity and cardiovascular disease: revisiting an old relationship","volume":"92","author":"Koliaki","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jot.2025.09.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jot.2025.09.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13679-023-00542-z","article-title":"Obesity and leukemia: biological mechanisms, perspectives, and challenges","volume":"13","author":"Tsilingiris","year":"2024","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.jot.2025.09.002_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s42000-022-00391-w","article-title":"Detangling the interrelations between MAFLD, insulin resistance, and key hormones","volume":"21","author":"Pal","year":"2022","journal-title":"Hormones (Basel)"},{"key":"10.1016\/j.jot.2025.09.002_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jot.2025.09.002_bib7","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jot.2025.09.002_bib8","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like Peptide-1 receptor agonists for weight loss","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jot.2025.09.002_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fendo.2014.00053","article-title":"Diabetes and osteoporosis - cause for concern?","volume":"5","author":"Vestergaard","year":"2014","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jot.2025.09.002_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ecl.2013.09.004","article-title":"Osteoporosis-associated fracture and diabetes","volume":"43","author":"Kurra","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jot.2025.09.002_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/joim.12725","article-title":"Type 2 diabetes mellitus and bone","volume":"283","author":"Compston","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.jot.2025.09.002_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40200-016-0275-1","article-title":"Mechanisms involved in altered bone metabolism in diabetes: a narrative review","volume":"15","author":"Ghodsi","year":"2016","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.jot.2025.09.002_bib13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","article-title":"The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial","volume":"92","author":"Grey","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jot.2025.09.002_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jc.2009-0572","article-title":"Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes","volume":"95","author":"Zinman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jot.2025.09.002_bib15","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-015-3660-2","article-title":"The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis","volume":"58","author":"Billington","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jot.2025.09.002_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A diabetes outcome progression trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jot.2025.09.002_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2015.07.025","article-title":"SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA\/2J Male mice","volume":"82","author":"Thrailkill","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.jot.2025.09.002_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1463-1326.2012.01630.x","article-title":"Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin","volume":"14","author":"Ljunggren","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jot.2025.09.002_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fendo.2020.00122","article-title":"The interplay between bone and glucose metabolism","volume":"11","author":"Cipriani","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jot.2025.09.002_bib20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.amjmed.2011.06.013","article-title":"Obesity is not protective against fracture in postmenopausal women: GLOW","volume":"124","author":"Compston","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jot.2025.09.002_bib21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbmr.235","article-title":"BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS)","volume":"26","author":"Nielson","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jot.2025.09.002_bib22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3389\/fendo.2019.00894","article-title":"A novel regulatory circuit \u201cC\/EBP\u03b1\/miR-20a-5p\/TOB2\u201d regulates adipogenesis and lipogenesis","volume":"10","author":"Zhou","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jot.2025.09.002_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.jot.2025.09.002_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jot.2025.09.002_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jot.2025.09.002_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(21)01443-4","article-title":"Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial","volume":"398","author":"Ludvik","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jot.2025.09.002_bib27","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(21)02188-7","article-title":"Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"398","author":"Del Prato","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jot.2025.09.002_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jama.2022.0078","article-title":"Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial","volume":"327","author":"Dahl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jot.2025.09.002_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jot.2025.09.002_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jama.2024.9217","article-title":"Tirzepatide for weight reduction in Chinese adults with obesity: the SURMOUNT-CN randomized clinical trial","volume":"332","author":"Zhao","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jot.2025.09.002_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.lfs.2013.01.001","article-title":"Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST\/Sclerostin in osteocytes","volume":"92","author":"Kim","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.jot.2025.09.002_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-009-9220-3","article-title":"Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states","volume":"84","author":"Nuche-Berenguer","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jot.2025.09.002_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114001","article-title":"Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors","volume":"177","author":"Yuliantie","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jot.2025.09.002_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-014-0361-4","article-title":"Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials","volume":"48","author":"Su","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.jot.2025.09.002_bib35","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2147\/DDDT.S358989","article-title":"Designing a dual GLP-1R\/GIPR agonist from tirzepatide: comparing residues between tirzepatide, GLP-1, and GIP","volume":"16","author":"Wang","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jot.2025.09.002_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.abp9960","article-title":"The microbiome and gut homeostasis","volume":"377","author":"Lee","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jot.2025.09.002_bib37","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jot.2025.09.002_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(15)00427-0","article-title":"The microbiome and critical illness","volume":"4","author":"Dickson","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jot.2025.09.002_bib39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s42255-022-00649-y","article-title":"Gut Parabacteroides merdae protects against cardiovascular damage by enhancing branched-chain amino acid catabolism","volume":"4","author":"Qiao","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.jot.2025.09.002_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jbspin.2018.02.008","article-title":"Gut microbiome and bone","volume":"86","author":"Ib\u00e1\u00f1ez","year":"2019","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.jot.2025.09.002_bib41","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/s41467-023-42005-y","article-title":"Gut microbiota impacts bone via bacteroides vulgatus-valeric acid-related pathways","volume":"14","author":"Lin","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jot.2025.09.002_bib42","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1038\/s41598-024-57122-x","article-title":"Mechanistic study on the alleviation of postmenopausal osteoporosis by Lactobacillus acidophilus through butyrate-mediated inhibition of osteoclast activity","volume":"14","author":"Dong","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jot.2025.09.002_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41467-017-02490-4","article-title":"Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jot.2025.09.002_bib44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jbmr.1588","article-title":"The gut microbiota regulates bone mass in mice","volume":"27","author":"Sj\u00f6gren","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jot.2025.09.002_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41413-023-00264-x","article-title":"Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis","volume":"11","author":"Lyu","year":"2023","journal-title":"Bone Res"},{"key":"10.1016\/j.jot.2025.09.002_bib46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41568-022-00504-y","article-title":"Key role for microbiota in gut-bone crosstalk","volume":"22","author":"Barranco","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jot.2025.09.002_bib47","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1172\/JCI128521","article-title":"The gut-bone axis: how bacterial metabolites bridge the distance","volume":"129","author":"Zaiss","year":"2019","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jot.2025.09.002_bib48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature12115","article-title":"Sema3A regulates bone-mass accrual through sensory innervations","volume":"497","author":"Fukuda","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jot.2025.09.002_bib49","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/IAI.00647-12","article-title":"Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family lachnospiraceae","volume":"80","author":"Reeves","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.jot.2025.09.002_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay9097","article-title":"Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites","volume":"370","author":"Guo","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jot.2025.09.002_bib51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jcmm.13955","article-title":"Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice","volume":"23","author":"Jin","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jot.2025.09.002_bib52","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2337\/dc18-0849","article-title":"Biochemical markers of bone turnover and risk of incident diabetes in older women: the cardiovascular health study","volume":"41","author":"Massera","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jot.2025.09.002_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.puhe.2019.11.001","article-title":"Association of obesity with bone mineral density and osteoporosis in adults: a systematic review and meta-analysis","volume":"180","author":"Qiao","year":"2020","journal-title":"Public Health"},{"key":"10.1016\/j.jot.2025.09.002_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: similarities and differences","volume":"1","author":"Seino","year":"2010","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jot.2025.09.002_bib55","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2337\/dc10-0704","article-title":"GIP: an inconsequential incretin or not?","volume":"33","author":"Pratley","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jot.2025.09.002_bib56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-8227(86)80017-1","article-title":"Osteopenia in mice with genetic diabetes","volume":"2","author":"Lorentzon","year":"1986","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jot.2025.09.002_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1153360","article-title":"The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats","volume":"10","author":"Jie","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.jot.2025.09.002_bib58","doi-asserted-by":"crossref","first-page":"454","DOI":"10.22203\/eCM.v041a29","article-title":"Gut microbial-derived short-chain fatty acids and bone: a potential role in fracture healing","volume":"41","author":"Wallimann","year":"2021","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.jot.2025.09.002_bib59","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/jpet.106.105569","article-title":"Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity","volume":"319","author":"Lin","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jot.2025.09.002_bib60","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.febslet.2009.10.046","article-title":"Evodiamine inhibits adipogenesis via the EGFR-PKCalpha-ERK signaling pathway","volume":"583","author":"Wang","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jot.2025.09.002_bib61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jcb.22109","article-title":"Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation","volume":"107","author":"Heo","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jot.2025.09.002_bib62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fphar.2018.00130","article-title":"Characterization of the in vitro metabolic profile of evodiamine in human liver microsomes and hepatocytes by UHPLC-Q exactive mass spectrometer","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jot.2025.09.002_bib63","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1124\/dmd.115.064386","article-title":"Intestinal absorption and metabolism of epimedium flavonoids in osteoporosis rats","volume":"43","author":"Zhou","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jot.2025.09.002_bib64","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.3390\/molecules26164778","article-title":"Screening papaveraceae as novel antibiofilm natural-based agents","volume":"26","author":"Zieli\u0144ska","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jot.2025.09.002_bib65","article-title":"Transforming berberine into its intestine-absorbable form by the gut microbiota","volume":"5","author":"Feng","year":"2015","journal-title":"Sci Rep"}],"container-title":["Journal of Orthopaedic Translation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214031X25001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214031X25001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:31:58Z","timestamp":1773160318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214031X25001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":65,"alternative-id":["S2214031X25001482"],"URL":"https:\/\/doi.org\/10.1016\/j.jot.2025.09.002","relation":{},"ISSN":["2214-031X"],"issn-type":[{"value":"2214-031X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Translation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jot.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Speaking Orthopaedic Society.","name":"copyright","label":"Copyright"}]}}